Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies
| Image |  |
|---|---|
| Description | scientific article published on 25 February 2019 |
| Author/s |
author: Swaminathan Padmanabhan |
| Publication date | February 25, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |